IPSC vs TT · rev $6.6M vs P/E 36, rev $21.32B
Century Therapeutics Inc (IPSC) versus Trane Technologies plc (TT) — a side-by-side from cached financials, not a winner call.
Century Therapeutics Inc (IPSC) is a biotechnology company listed on US.
Trane Technologies plc (TT) is a building products & equipment company listed on NYSE.
Latest reported IPSC revenue for 2024-12-31 was $6.6M. Net income was -$126.6M. Revenue was up 194.8% from 2023-12-31 to 2024-12-31. IPSC currently screens at market cap $47.8M.
Latest reported TT revenue for 2025-12-31 was $21.32B. Net income was $2.92B. Revenue was up 7.5% from 2024-12-31 to 2025-12-31. TT currently screens at market cap $104.45B and trailing P/E 36.2.
IPSC currently screens at market cap $47.8M. TT currently screens at market cap $104.45B and trailing P/E 36.2.
Not investment advice. Open the IPSC and TT stock pages for the full models.
Not investment advice.